stockrow
Friday 6 November 2026
Export HNGE’s income statement to Excel — free account
Hinge Health Inc.
HNGE Healthcare Health Information Services
Hinge Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $587.9 million, up 50.6% from fiscal 2024.
- Revenue
- +53.0%
- EPS
- +104.2%
- Free cash flow
- +441.1%
Quarter to June 2026, against a year earlier
115.84
0.14
−0.12%
Follow HNGE
Alert me
Hinge Health Inc. (HNGE) Shares outstanding
Hinge Health Inc.'s shares outstanding at the end of fiscal 2025 was $54.6M, up 302.5% from $13.6M in fiscal 2024. At the end of the quarter to 30 June 2026 it was $83.4M. Hinge Health Inc. ranks 17th of 43 Health Information Services companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $54.6M | 302.54% |
| FY2024 | $13.6M | 4.16% |
| FY2023 | $13.0M | — |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Jun 2026 | $83.4M | 1.25% |
| Mar 2026 | $82.4M | 50.97% |
| Dec 2025 | $54.6M | (30.79%) |
| Sep 2025 | $78.9M | 79.50% |
| 4 more quarters | Free account |
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| BTSG BrightSpring Health Services, Inc. compare | $220.2M |
| WAY Waystar Holding Corp. compare | $195.9M |
| DOCS Doximity, Inc. compare | $187.8M |
| TEM Tempus AI, Inc. compare | $181.3M |
| PRVA Privia Health Group, Inc. compare | $132.7M |
| HTFL Heartflow, Inc. compare | $86.4M |
| HQY HealthEquity, Inc. compare | $84.0M |
| HNGE Hinge Health Inc. | $83.4M |
| SDGR Schrodinger, Inc. compare | $74.9M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on HNGE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Book value per share
- The full statement